Can a zoom program curb drinking and boost bystander action?
NCT ID NCT05873413
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a motivational interviewing program delivered over Zoom can increase bystander intervention in sexual risk situations and reduce alcohol use among heavy-drinking young adults aged 18-25. 450 participants will be assigned to one of three groups: a bystander-only program, a combined bystander-plus-alcohol program, or a stress-reduction control. They will complete online surveys, a virtual reality simulation, and daily diaries for 9 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Motivational interviewing prevention program
- What this could lead to
- If successful, this could provide an effective, scalable program to reduce sexual violence and heavy drinking among young adults.
- What could go wrong
- This is a behavioral intervention trial with self-reported outcomes, so results may be influenced by participant bias. The study is also limited to one geographic area.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 450 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2024
- Expected to finish
-
May 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Individuals ages 18-25 * Heavy drinkers (as defined by using the AUDIT) * English fluency * Community members from Lancaster and surrounding counties in Nebraska * Signed and dated consent form * Stated willingness to comply with study procedures Exclusion Criteria: This project does not have any pre-determined exclusion criteria beyond the need to meet inclusion criteria for the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol drinking are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Nebraska-Lincoln
RECRUITINGLincoln, Nebraska, 68588, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a WhatsApp chatbot help keep children safer?
- Digital tool aims to alert women to alcohol and breast cancer risk
- Family online sessions aim to shield LGBTQ+ teens from alcohol and dating abuse
- A tailored online program takes on campus drinking and sexual assault
- Texts at the right moment may curb Alcohol-Fueled partner violence
- Gut bacteria pill may shield HIV patients from heart disease